Cara Therapeutics Inc (NAS:CARA)
$ 0.2908 -0.0132 (-4.34%) Market Cap: 15.95 Mil Enterprise Value: -21.94 Mil PE Ratio: 0 PB Ratio: 29.08 GF Score: 33/100

Q4 2021 Cara Therapeutics Inc Earnings Call Transcript

Mar 01, 2022 / 09:30PM GMT
Release Date Price: $10.06 (-2.99%)
Operator

Good afternoon. My name is Andrew, and I will be your conference facilitator. I would like to welcome everyone to the Cara Therapeutics Fourth Quarter 2021 Financial Results and Update Conference Call. (Operator Instructions) Please be advised that this call is being recorded.

I would now like to introduce Iris Francesconi, Interim Head of Investor Relations from Cara Therapeutics. Ms. Francesconi, you may begin your call.

Iris Francesconi

Thank you, Andrew, and good afternoon. Just after market closed today, we issued a press release detailing our corporate progress and financial results for the fourth quarter and full year 2021. The press release can be found on our website at www.caratherapeutics.com. You may also listen to a live webcast and replay of today's call on the Investors section of the website. Participating in today's call are Chris Posner, Cara's President and Chief Executive Officer; Tom Reilly, Cara's Chief Financial Officer; and Joana Goncalves, Cara's Chief Medical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot